Periconceptional folate intake and neural tube defects.

Journal of the American College of Nutrition

Volumn 15, Issue 2, 1996, Pages 121-125

  Rayburn, William F ^a   Stanley, John R ^a   Garrett, M Elaine ^a,b  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

COST BENEFIT ANALYSIS; DIET SUPPLEMENTATION; DIETARY INTAKE; FOLIC ACID DEFICIENCY; HEALTH CARE POLICY; HUMAN; INCIDENCE; NEURAL TUBE DEFECT; PREGNANCY COMPLICATION; PREVALENCE; PROPHYLAXIS; REVIEW;

ADOLESCENT; ADULT; COST-BENEFIT ANALYSIS; FEMALE; FOLIC ACID; HUMANS; INCIDENCE; NEURAL TUBE DEFECTS; PREGNANCY; PUBLIC POLICY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0029867217     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.1996.10718576     Document Type: Article

References (32)

1. Rose NC, Meunuti MT: Periconceptional folate supplementation and neural tube defects. Clin Obstet Gynecol 37:695-20, 1994.
2. –Nutrition During Pregnancy.— Washington DC: National Academy of Sciences, p 412, 1990.
3. National Research Council: –Recommended Dietary Allowance,— 10 ed. Report of the Subcommittee on the Tenth Edition of RDAs, Food and Nutrition Board, Commission on Life Sciences. Washington, DC: National Academy Press, 1989.
4. Jaskoll T, Greenberg G, Melnick M: Neural tube and neural crest: a new view with time-lapse high-definitions photomicroscopy. Am J Med Genet 41:333-345, 1991.
5. Moore KL, Persand TVS: The nervous system. In Moore KL, Persand TVS (eds): –The Developing Human,— 5 ed. Philadelphia: WB Saunders, pp 385-22, 1993.
6. Lynberg MC, Khoury MJ: Contribution of birth defects to infant mortality among racial/ethnic minority groups. United States, 1983. Mortal Morbid Weekly Report 39(55-3): 1-12, 1990.
7. Reider MJ: Prevention of neural tube defects with periconceptional folic acid. Clinics in Perinatology 21:483-503, 1994.
8. Economic burden of spina bifida-United States, 1980-1990. Mortal Morbid Weekly Report 38:264-267, 1989.
9. Chung CS, Myrianthopoupos NC: Racial and prenatal factors in major congenital malformations. Am J Hum Genet 20:44-60, 1968.
10. Milunsky A, Ulcickas M, Rothman KJ, Willett W, Jick SS, Jicj H: Maternal heart exposure and neural tube defects. JAMA 268:882-885, 1992.
11. Main DMM. Mennuti MT: Neural tube defects. Issues in prenatal diagnosis and counseling. Obstet Gynecol 67:1-15, 1986.
12. Wilson RD, Van Allen MI: Recommendations on the use of folic acid for the prevention of neural tube defects. J Soc Obstet Gynecol 15(suppl):41-44, 1993.
13. American College of Obstetricians and Gynecologists: –Guidelines for Perinatal Care,— 3rd ed. Washington DC: ACOG, pp 177-181, 1992.
14. Laurence KM, James N, Miller MH, Tennan GB, Campbell H: Double-blind randomized controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. Br Med J 282:1509-1511, 1981.
15. Smithells RW, Nevin NC, Seller MJ, Shepard S, Harris R, Read AP: Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 1:1027-1031, 1983.
16. MRC Vitamin Study Research Group: Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338:131-133, 1991.
17. Vergei RH, Sanchez LR, Hcrcdro BL, Rodriguez P, Martinez A: Primary prevention of neural tube defects with folic acid supplementation: Cuban experience. Prenatal Diagn 19:149-152, 1990.
18. Centers for Disease Control and Prevention: Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. Mortal Morbid Weekly Report 44(44-14): 1-7, 1992.
19. Mills JL, Rhoads GG, Simpson JL, Cunningham GC, Conley MR, Lassman MR: The absence of a relationship between the periconceptional use of vitamins and neural tube defects. N Engl J Med 321:430-435, 1989.
20. Mulinare J, Cardero JF, Erickson JD, Berry RJ: Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 260:3141-3145, 1988.
21. Bower C, Stanley FJ: Dietary folate as a risk factor for neural tube defects: evidence from a case-control study in Western Australia. Med J Aust 150:613-619, 1989.
22. Werler M, Shapiro S, Mitchell A: Perinconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 269: 1257-1262, 1993.
23. Milunsky A, Jick H, Jick SS, Breli CL, MacLaughlin O, Rothman K: Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 262:2847-2852, 1989.
24. Czeizel A, Ddas I: Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplemental. N Engl J Med 327:1832-1836, 1992.
25. Centers for Disease Control and Prevention: Use of folic acid for prevention of spina bifida and other neural tube defects. Mortal Morbid Weekly Report 40:513-516, 1991.
26. Folic acid-fortified foods. FDA Med Bull, May, 1994.
27. Food labelling: health claims and label statements; folate and neural tube defects. Fed Regis 58:53254-53295, 1993.
28. American College of Obstetricians and Gynecologists (ACOG) Committee Opinion: Folic acid for the prevention of recurrent neural tube defects. Number 120, March, 1993.
29. Grimes DA: Unplanned pregnancies in the U.S. Obstet Gynecol 677:438-442, 1986.
30. Fuller NJ: The effect of dietary folate and zinc on the outcome of pregnancy and early growth in rats. Br J Nutr 59:215-219, 1988.
31. Ghishan FK: Mutual inhibitory effects of GI transport of zinc and folate. Am J Clin Nutr 3:258-262, 1968.
32. Romano PS, Weitzman NJ, Scheffler RM, Pi RD: Folic acid fortification of grain: an economic analysis. Am J Public Health 85:667-676, 1995.